Advances in IBS Therapy and Its Affect on IBS Sufferers

Newswise — WHO:

The American College of Gastroenterology (ACG) is an association ofmore than 8,000 gastrointestinal (GI) professionals committed to thescientific study and medical treatment of disorders of the gastrointestinal(GI) tract.

WHAT:

Irritable bowel syndrome (IBS) is one of the most common GI disorders in the United States, affectng over 58 million Americans. It is characterized by recurring symptoms of abdominal discomfort or pain, bloating, and an altered bowel habit, either constipation, diarrhea or both. Data indicates that women are 2-3 times more likely to have IBS than men.

GI specialists will address new insights into this disorder, advances in IBS pharmacology and what this means for those with the disorder.

EXPERTS: Lawrence J. Brandt, M.D., MACG, Montefiore Hospital, Bronx, NYKevin W. Olden, M.D., FACG, Mayo Clinic, Scottsdale, AZYuri Saito, M.D., MPH, Mayo Clinic, Rochester, NY

WHERE: Ballroom VIP Room, Baltimore Convention Center, Baltimore, Maryland

WHEN: Monday, October 13, 2003, 12:30 PM (EDT)